Evidence map›Paper›PMID 22190006›Full record

GuidelineVirchows Archiv : an international journal of pathology2012

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

M Dinis-Ribeiro, M Areia, A C de Vries, R Marcos-Pinto, M Monteiro-Soares, A O'Connor, C Pereira, P Pimentel-Nunes, R Correia, A Ensari and 19 more

Abstract readConsensus StatementPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Virchows Archiv : an international journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
  12. Statistical proof ofWorld journal of gastrointestinal surgery · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 11 countries.

M Dinis-RibeiroDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Rua Dr. Bernardino de Almeida 4200-072, Porto, Portugal. mdinisribeiro@gmail.com
M Areia
A C de Vries
R Marcos-Pinto
M Monteiro-Soares
A O'Connor
C Pereira
P Pimentel-Nunes
R Correia
A Ensari
J M Dumonceau
J C Machado
G Macedo
P Malfertheiner
T Matysiak-Budnik
F Megraud
K Miki
C O'Morain
R M Peek
T Ponchon
A Ristimaki
B Rembacken
F Carneiro
E J Kuipers
MAPS Participants
European Society of Gastrointestinal Endoscopy
European Helicobacter Study Group
European Society of Pathology
Sociedade Portuguesa de Endoscopia Digestiva
Universidade do Porto · PTInstituto Português de Oncologia Francisco Gentil · PTAnkara University · TRErasmus MC · NLLeeds General Infirmary · GBUniversité de Bordeaux · FRVanderbilt University · USCentre Hospitalier Universitaire de Nantes · FRHospital de São João · PTTrinity College Dublin · IEUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with these premalignant conditions. The European Society of Gastrointestinal Endoscopy, the European Helicobacter Study Group, the European Society of Pathology, and the Sociedade Portuguesa de Endoscopia Digestiva have therefore combined efforts to develop evidence-based guidelines on the management of patients with precancerous conditions and lesions of the stomach. A multidisciplinary group of 63 experts from 24 countries developed these recommendations by means of repeat online voting and a meeting in June 2011 in Porto, Portugal. The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia and the need for adequate staging in the case of high-grade dysplasia, and they focus on treatment and surveillance indications and methods.

Indexed as

AtrophyEndoscopy, GastrointestinalEuropeGastritisHumansMetaplasiaPortugalPrecancerous ConditionsRisk FactorsSocieties, MedicalStomachStomach Neoplasms

Identifiers

PMID22190006
OpenAlexW2512071448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.